These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6189954)

  • 1. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.
    Hylton W; Cayley J; Dore C; Denman AM
    Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of interferons produced by peripheral blood mononuclear cells from healthy subjects in response to Corynebacterium parvum or poly I: poly C.
    Hertzog PJ; Cheetham BF; Sexton JL; Linnane AW
    Biochem Int; 1989 Dec; 19(6):1427-36. PubMed ID: 2483976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 7. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
    Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
    J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
    Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-inducible genes 2', 5'-ollgoadenylate synthetase-like and tetratricopeptide repeats 2 are correlated with clinical features of patients with systemic lupus erythematosus].
    Zhao ZY; Yang NP; Huang XY; Min L; Liu XX; Zhang J; Ye Y; Shi LJ; Zhong X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):247-51. PubMed ID: 20506645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigations of interferon and oligo-2',5'-adenylate systems in endogenous uveitis].
    Kotake S
    Hokkaido Igaku Zasshi; 1988 May; 63(3):398-406. PubMed ID: 2455682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons in rheumatoid arthritis: alterations in production and response related to disease activity.
    Hertzog PJ; Emery P; Cheetham BF; Mackay IR; Linnane AW
    Clin Immunol Immunopathol; 1988 Aug; 48(2):192-201. PubMed ID: 2455616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes in various diseases.
    Fujii N; Kotake S; Hirose S; Ohno S; Yasuda I; Sagawa A; Ishikawa K; Minagawa T
    J Clin Microbiol; 1984 Dec; 20(6):1216-8. PubMed ID: 6520229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
    Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
    Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
    Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
    Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent interferonemia and interferon responses in multiple sclerosis.
    Hertzog PJ; Wright A; Harris G; Linnane AW; Mackay IR
    Clin Immunol Immunopathol; 1991 Jan; 58(1):18-32. PubMed ID: 1701372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.